4//SEC Filing
Boylan James P 4
Accession 0001415889-25-016991
CIK 0001472012other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 5:00 PM ET
Size
5.9 KB
Accession
0001415889-25-016991
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Boylan James P
Director
Transactions
- Award
Director Stock Option (right to buy)
2025-06-10+18,864→ 18,864 totalExercise: $9.57Exp: 2035-06-09→ Common Stock (18,864 underlying)
Footnotes (2)
- [F1]Mr. Boylan has agreed to receive and hold for the benefit of Enavate Sciences, LP, any securities granted to him for his service as a director on the Company's board of directors. As such, Mr. Boylan disclaims beneficial ownership of, and all right, title and interest in, the reported securities.
- [F2]The option vests in four quarterly installments, commencing from June 10, 2025 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to Mr. Boylan's continuous service with the Company on each respective vesting date.
Documents
Issuer
Immunome Inc.
CIK 0001472012
Entity typeother
Related Parties
1- filerCIK 0001953094
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 5:00 PM ET
- Size
- 5.9 KB